Mitinab 400 mg Tablet
  1. Home
  2. Pharma Products
  3. Glenmark Pharmaceuticals Ltd
  4. Mitinab 400 mg Tablet

Mitinab 400 mg Tablet

Mitinab 400 mg Tablet contains imatinib mesylate 400 mg and is an oral targeted anticancer medicine used for certain blood cancers and gastrointestinal stromal tumors. It is taken by mouth with food and a large glass of water according to the prescribed treatment plan. Imatinib blocks specific tyrosine kinases involved in abnormal cancer-cell growth.

BUY NOW

Category

Mitinab is a tyrosine kinase inhibitor used in appropriate treatment regimens for conditions such as chronic myeloid leukemia, acute lymphoblastic leukemia, and gastrointestinal stromal tumors. It works by inhibiting signaling proteins including BCR-ABL and other tyrosine kinases that contribute to the proliferation of abnormal cells. The dose and duration depend on the specific disease and the patient’s response to treatment. Regular blood counts and liver-function monitoring may be recommended during therapy because imatinib can cause edema, nausea, muscle cramps, diarrhea, rash, and other adverse effects.

Technical Specification

Specification Details
Active Ingredient Imatinib Mesylate
Strength 400 mg
Dosage Form Tablet
Route of Administration Oral
Therapeutic Class Antineoplastic
Manufacturer/Marketer Glenmark Pharmaceuticals Ltd

Product Also Known As

Mitinab 400mg Tablet, Mitinab 400 mg Tablet, Imatinib Mesylate 400mg Tablet, Imatinib 400mg Tablet, Imatinib Mesylate Tablet 400mg, Imatinib Tyrosine Kinase Inhibitor Tablet